Go Long on Clorox

CLX: The Sleeper Stock That Could Hit $120

Clorox (NYSE: CLX) may be one of the more overlooked turnaround opportunities in the consumer-staples sector.

Trading around $100, CLX sits well below its historical highs, creating a potentially attractive entry point for investors willing to wait for a recovery.

Why CLX Could Reach $120

1. Powerful brands

Clorox owns household staples including Clorox, Glad, Kingsford, Fresh Step, Hidden Valley, Brita, Burt’s Bees, and Pine-Sol. Roughly 80% of its brands rank No. 1 or No. 2 in their categories.

This dominant positioning supports strong pricing power and consistent consumer demand.

2. Historical range supports upside

CLX has a long history of trading well above current levels:

● 52-week high: ~$130

● 52-week low: ~$95

● Recent trading range (past year): roughly $95–$130

● All-time / multi-year peaks: above $170 during stronger earnings cycles

At today’s ~$100 level, the stock is closer to the lower end of its recent range, suggesting potential room for normalization.

A move back to $120 would represent ~20% upside, still below prior highs and within its historical trading behavior.

3. Turnaround potential

Clorox is currently navigating:

● Declining organic sales

● Margin pressure

● ERP system transition costs

These headwinds have compressed earnings and weighed on sentiment.

If management stabilizes growth and restores margins, the market could re-rate CLX based on normalized earnings power rather than temporary disruption.

4. GOJO adds another major brand

The acquisition of GOJO Industries, including the PURELL brand, strengthens Clorox’s position in the high-demand health and hygiene category.

This expands its portfolio of essential consumer products and adds long-term strategic value.

5. Investors get paid to wait

Clorox pays a $1.24 quarterly dividend, or $4.96 annually.

At ~$100 per share, that’s roughly a 5% dividend yield, offering meaningful income while waiting for a potential recovery.

The Bottom Line

CLX is not a high-growth story—it’s a stability and recovery play.

With:

● Iconic household brands

● Strong category leadership

● A ~5% dividend yield

● And a depressed valuation relative to historical highs

…the setup offers an interesting risk/reward profile.

If Clorox stabilizes operations and returns toward historical valuation levels, $120 becomes a reasonable upside target, representing a potential ~20% gain plus dividends.

This is an investment thesis, not financial advice. CLX carries risks including weak sales trends, margin pressure, and execution challenges.